The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs
- PMID: 17967639
- DOI: 10.1016/j.otohns.2007.05.068
The protective effect of intratympanic dexamethasone on cisplatin-induced ototoxicity in guinea pigs
Abstract
Objective: The purpose of this study was to investigate the effectiveness of intratympanic dexamethasone injection as a protection agent against cisplatin-induced ototoxicity.
Study design and setting: The four groups of guinea pigs were injected as follows: 1) cisplatin, 2) intratympanic dexamethasone, 3) cisplatin following intratympanic dexamethasone, and 4) cisplatin after intratympanic saline. Before and 3 days following injections, the ototoxic effect was measured with distortion product otoacoustic emissions (DPOAEs).
Results: The DPOAEs amplitudes and signal-to-noise ratio (SNR) values at 1 to 6 kHz frequencies for group 1 animals after injections significantly decreased over those before injections (P < 0.05). In group 2, there were no significant differences in DPOAE amplitude and SNR values between before and after intratympanic dexamethasone injections (P > 0.05). Considering group 3, there were also no significant differences in DPOAEs amplitudes and SNR values before and after of dexamethasone and cisplatin injections (P > 0.05).
Conclusions: Intratympanic dexamethasone injection did not cause any ototoxic effect; in contrast, it might have a significant protective effect after cisplatin injection.
Similar articles
-
Effect of intratympanic dexamethasone administration on cisplatin-induced ototoxicity in adult guinea pigs.Auris Nasus Larynx. 2013 Feb;40(1):51-60. doi: 10.1016/j.anl.2012.05.010. Epub 2012 Aug 11. Auris Nasus Larynx. 2013. PMID: 22884636
-
Can intratympanic dexamethasone protect against cisplatin ototoxicity in mice with age-related hearing loss?Otolaryngol Head Neck Surg. 2011 Oct;145(4):635-40. doi: 10.1177/0194599811409304. Epub 2011 May 13. Otolaryngol Head Neck Surg. 2011. PMID: 21572077
-
Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.Ear Hear. 2008 Dec;29(6):875-93. doi: 10.1097/AUD.0b013e318181ad99. Ear Hear. 2008. PMID: 18753950 Clinical Trial.
-
[Research progress on mechanism of cisplatin ototoxicity and protective agents against the ototoxic effects].Sheng Li Ke Xue Jin Zhan. 2003 Jul;34(3):266-9. Sheng Li Ke Xue Jin Zhan. 2003. PMID: 14628479 Review. Chinese. No abstract available.
-
Effect of tympanic perforations on the detection of distortion-product otoacoustic emissions.Ear Nose Throat J. 2000 Aug;79(8):610-2, 614-6, 618. Ear Nose Throat J. 2000. PMID: 10969471 Review.
Cited by
-
Cisplatin ototoxicity and protection: clinical and experimental studies.Tohoku J Exp Med. 2009 Nov;219(3):177-86. doi: 10.1620/tjem.219.177. Tohoku J Exp Med. 2009. PMID: 19851045 Free PMC article. Review.
-
Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.Braz J Otorhinolaryngol. 2020 Jan-Feb;86(1):30-37. doi: 10.1016/j.bjorl.2018.08.002. Epub 2018 Sep 14. Braz J Otorhinolaryngol. 2020. PMID: 30268784 Free PMC article.
-
Inner Ear Drug Delivery for Sensorineural Hearing Loss: Current Challenges and Opportunities.Front Neurosci. 2022 May 24;16:867453. doi: 10.3389/fnins.2022.867453. eCollection 2022. Front Neurosci. 2022. PMID: 35685768 Free PMC article. Review.
-
Cisplatin-Induced Hearing Loss, Oxidative Stress, and Antioxidants as a Therapeutic Strategy-A State-of-the-Art Review.Antioxidants (Basel). 2024 Dec 21;13(12):1578. doi: 10.3390/antiox13121578. Antioxidants (Basel). 2024. PMID: 39765905 Free PMC article. Review.
-
Systemic dexamethasone for the prevention of cisplatin-induced ototoxicity.Eur Arch Otorhinolaryngol. 2013 May;270(5):1597-605. doi: 10.1007/s00405-012-2150-0. Epub 2012 Aug 21. Eur Arch Otorhinolaryngol. 2013. PMID: 22907029
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical